[1]
2026. IP Challenges with Combination Drug Patents in Pharmaceuticals: A Critical Analysis. Journal of Intellectual Property Rights (JIPR). 31, 4 (Jul. 2026), 467–473. DOI:https://doi.org/10.56042/jipr.v31i4.15977.